Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at SEK 1.4T, ahead of Pfizer (SEK 1.24T) and Johnson & Johnson (SEK 1.2T). Figures as of 19 Nov 2026, 20:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSEK 1.4T
- Median
- SEK 21.2B
- Combined market value
- SEK 50.51T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 1.4T | SEK 5.09T | SEK 2,879.87 | 1.17% down | 25% up | ||
| 2 | PfizerPFE · Health Care | SEK 1.24T | SEK 1.6T | SEK 280.40 | 1.92% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SEK 1.2T | SEK 6.53T | SEK 2,710.65 | 2.43% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | SEK 875.6B | SEK 12.28T | SEK 13,789.80 | 2.11% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | SEK 857.9B | SEK 3.33T | SEK 1,348.80 | 3.91% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SEK 728.8B | SEK 1.21T | SEK 593.15 | 2.25% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | SEK 665.8B | SEK 2.76T | SEK 1,782.03 | 2.15% down | 1% up | ||
| 8 | NovartisNVS · Health Care | SEK 656.1B | SEK 2.91T | SEK 1,538.30 | 2.72% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SEK 622.8B | SEK 1.13T | SEK 468.70 | 2.37% down | 4% down | ||
| 10 | GSKGSK · Health Care | SEK 610.7B | SEK 975.4B | SEK 486.63 | 1.68% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | SEK 527.4B | SEK 1.74T | SEK 394.08 | 1.90% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SEK 515.6B | SEK 698.4B | SEK 218.59 | 0.87% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SEK 345.8B | SEK 1.83T | SEK 1,057.54 | 0.65% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 334.5B | SEK 462.8B | SEK 396.67 | 7.80% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SEK 229B | SEK 231.9B | SEK 202.28 | 2.10% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | SEK 136.9B | SEK 57.1B | SEK 83.85 | 2.83% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | SEK 123.6B | SEK 335.6B | SEK 825.90 | 5.26% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SEK 100.9B | SEK 397.4B | SEK 691.06 | 1.22% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SEK 94.8B | SEK 976.6B | SEK 9,440.04 | 2.00% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 74.8B | SEK 152.9B | SEK 2,382.39 | 5.62% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | SEK 71.6B | SEK 321.3B | SEK 521.12 | 0.35% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SEK 71.1B | SEK 1.34T | SEK 5,290.78 | 3.20% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SEK 69.4B | SEK 135B | SEK 270.09 | 0.71% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 42.6B | SEK 202.8B | SEK 1,514.05 | 0.53% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SEK 39B | SEK 465.5B | SEK 4,074.83 | 0.90% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SEK 37.4B | SEK 75.7B | SEK 217.21 | 2.56% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SEK 31.6B | SEK 49.9B | SEK 597.43 | 2.64% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SEK 30.9B | SEK 45.8B | SEK 274.77 | 1.53% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SEK 30.7B | SEK 155.2B | SEK 796.91 | 0.27% up | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 21.6B | SEK 126.3B | SEK 151.50 | 0.73% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | SEK 21.2B | SEK 73B | SEK 523.77 | 0.18% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | SEK 16.6B | SEK 170.5B | SEK 2,599.14 | 5.63% down | 29% up | ||
| 33 | InsmedINSM · Health Care | SEK 15.5B | SEK 324.1B | SEK 1,477.27 | 21.04% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SEK 15.4B | SEK 121.8B | SEK 628.61 | 0.44% up | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 9B | SEK 62.3B | SEK 441.04 | 0.42% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SEK 8B | SEK 243.9B | SEK 5,726.02 | 2.65% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | SEK 7.5B | SEK 31.8B | SEK 164.13 | 0.86% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | SEK 6.8B | SEK 79.3B | SEK 472.01 | 1.11% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.7B | SEK 93.9B | SEK 4,041.11 | 0.36% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SEK 6.1B | SEK 72.5B | SEK 1,378.65 | 0.99% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SEK 5.5B | SEK 58.5B | SEK 2,925.87 | 3.86% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.4B | SEK 63.6B | SEK 974.80 | 3.45% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 46.8B | SEK 487.65 | 4.73% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | SEK 4.2B | SEK 288.1B | SEK 397.64 | 0.77% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SEK 4.2B | SEK 100.5B | SEK 664.77 | 1.32% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SEK 3.1B | SEK 49.5B | SEK 284.45 | 0.40% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 2.1B | SEK 82.7B | SEK 1,193.54 | 1.59% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 2B | SEK 74.9B | SEK 952.99 | 1.59% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SEK 1.9B | SEK 72.5B | SEK 662.28 | 4.11% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | SEK 1.5B | SEK 72.4B | SEK 826.71 | 3.20% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SEK 1.1B | SEK 41.1B | SEK 299.89 | 1.08% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SEK 940.6M | SEK 85.5B | SEK 106.87 | 0.10% down | 36% down | ||
| 53 | ErascaERAS · Health Care | SEK 723.2M | SEK 50.6B | SEK 144.26 | 2.91% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SEK 637.2M | SEK 94.9B | SEK 999.15 | 3.34% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SEK 609M | SEK 88.9B | SEK 3,181.74 | 2.33% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SEK 544.9M | SEK 83B | SEK 1,270.97 | 1.90% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SEK 382.3M | SEK 48.9B | SEK 869.20 | 1.59% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SEK 309.2M | SEK 45.9B | SEK 419.65 | 0.44% down | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SEK 170M | SEK 67.5B | SEK 994.97 | 2.01% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | SEK 102.6M | SEK 63.1B | SEK 1,554.14 | 2.36% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | SEK 93.3M | SEK 52.8B | SEK 1,252.32 | 1.55% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1881 SEK).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (SEK 1.4T), Pfizer (SEK 1.24T) and Johnson & Johnson (SEK 1.2T) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 19 Nov 2026, 20:26 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of SEK 50.51T as of 19 Nov 2026, 20:26 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.